Key Differences When Switching Between Weight Management Options
Why Consider Switching From Wegovy To Mounjaro UK - In Stock Availability
When switching from Wegovy to Mounjaro in the UK, availability often drives the decision. Both prescription-only medicines are currently in stock at EverydayMeds, eliminating the historical supply concerns that have affected these treatments. Wegovy operates through a GLP-1 receptor agonist mechanism, whilst Mounjaro utilises a dual GIP and GLP-1 receptor approach. Your prescriber can assess which mechanism may be more suitable based on your individual response and medical history. The choice between these treatments should always involve clinical guidance rather than availability alone.
Understanding the switching process from Wegovy to Mounjaro requires careful consideration of dosing schedules and mechanisms. Both treatments require dose escalation periods, meaning any switch should be properly managed by a healthcare professional. At EverydayMeds, our clinical team can guide you through the assessment process for either treatment. The fact that both are readily available means your choice can be based purely on clinical suitability rather than supply constraints. This availability advantage ensures continuity of care for patients requiring weight management support.
Pricing Comparison When Switching From Wegovy To Mounjaro UK Options
Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers benefit from the FIRST40 discount code applied at checkout, whilst returning customers use DOSE25. Bundle options provide convenient multi-month supplies, such as the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99. These prices reflect the final amount after discount codes are applied, ensuring transparent pricing throughout your treatment journey.
When comparing costs for switching from Wegovy to Mounjaro, both treatments require similar dose escalation periods and ongoing maintenance dosing. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, offering convenience for established patients. Bundle pricing focuses on convenience rather than savings, ensuring Reliable Supply and reducing the frequency of orders. This pricing structure allows patients and prescribers to focus on clinical suitability rather than cost fluctuations when making switching decisions.
Clinical Evidence For Switching From Wegovy To Mounjaro UK Patients
Wegovy's clinical evidence comes from the STEP trial programme, where patients achieved approximately 15% average weight loss at 68 weeks when combined with diet and exercise (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events. These results established Wegovy's efficacy profile for weight management in eligible patients with BMI ≥30 or BMI ≥27 with comorbidities.
Mounjaro's evidence base derives from the SURMOUNT trials, showing its dual GIP and GLP-1 mechanism in weight management contexts. Both treatments have different trial designs and populations, making direct comparison inappropriate. When switching from Wegovy to Mounjaro, your prescriber will consider your individual response to the previous treatment, any side effects experienced, and your specific clinical circumstances to determine the most appropriate option.
How Wegovy Works For UK Patients Switching Treatment Options
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones. This mechanism works on the brain's appetite centres, promoting feelings of fullness and reducing food cravings between meals. The treatment slows gastric emptying, meaning food remains in the stomach longer, contributing to sustained satiety signals. Wegovy is administered once weekly via the FlexTouch pre-filled pen, providing consistent hormone levels throughout the week. The dose escalation schedule from 0.25mg to 2.4mg allows the body to gradually adjust to the medication whilst minimising potential side effects. This mechanism differs from Mounjaro's dual approach, which targets both GLP-1 and GIP receptors simultaneously.
Ordering Process When Switching From Wegovy To Mounjaro UK Supply
The ordering process at EverydayMeds begins with a 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our prescribers review applications within 3 working days as standard, with express 24-hour review available for urgent cases. Once approved, your prescription is prepared by our GPhC-registered pharmacy (#9012878) and dispatched via next-day cold-chain delivery. The temperature-controlled packaging ensures medication integrity throughout transit, maintaining the required 2-8°C storage conditions. Whether switching from Wegovy to Mounjaro or starting either treatment, the same rigorous clinical and pharmacy standards apply. Patients receive full dosing instructions, storage guidance, and ongoing support throughout their treatment journey.
Storage Advantages When Switching From Wegovy To Mounjaro UK Treatments
Wegovy offers significant storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from the fridge, whilst Mounjaro maintains stability for only 21 days. Both treatments require refrigeration at 2-8°C before first use, but Wegovy's extended room temperature tolerance provides greater convenience for travel and daily use. The FlexTouch pen design allows for easy dose selection and administration, with clear dosing windows and automatic needle insertion. Dose escalation follows a structured schedule over 16 weeks, reaching the 2.4mg maintenance dose, with some patients requiring the newly approved 7.2mg dose. This storage advantage becomes particularly relevant for patients with busy lifestyles or frequent travel requirements. The practical benefits of extended temperature stability often influence treatment choice alongside clinical considerations.
Stock Reliability When Switching From Wegovy To Mounjaro UK Pharmacies
EverydayMeds maintains reliable stock levels for both Wegovy and Mounjaro through established supply chains with Novo Nordisk and Eli Lilly respectively. This dual availability means patients considering switching from Wegovy to Mounjaro can make decisions based on clinical suitability rather than supply constraints. Our pharmacy management systems monitor stock levels across all dose strengths, ensuring continuity of supply for both starter and maintenance phases. Historical supply challenges with weight management medications have emphasised the importance of reliable pharmacy partnerships.
The ability to switch between treatments without supply interruptions provides important flexibility for patients and prescribers. Both treatments are subject to the same rigorous cold-chain handling and storage requirements, ensuring medication quality regardless of which option is chosen. This reliable availability removes previous barriers that may have influenced treatment decisions based on supply rather than clinical factors. Patients can therefore focus on working with their prescriber to determine the most suitable long-term weight management strategy.
Making Your Decision When Switching From Wegovy To Mounjaro UK Options
Your prescriber will consider several factors when assessing a potential switch from Wegovy to Mounjaro, including your response to previous treatment, any side effects experienced, and your individual clinical profile. Both treatments work alongside a reduced-calorie diet and increased physical activity as part of comprehensive weight management programmes. The decision should never be based solely on availability or cost considerations, but rather on which treatment mechanism may be most suitable for your circumstances. EverydayMeds provides access to both options, allowing clinical considerations to drive the decision-making process. Remember that both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your weight management goals and medical history. Starting either treatment requires commitment to the full dose escalation schedule and ongoing lifestyle modifications for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
